Cannabis 2.0 Is Ready to Supercharge These Stocks

Cannabis stocks are the wild west. While there’s early optimism (plus plenty of pessimism), no one is entirely sure what the future will look like. The regulatory environment is quickly improving, but the future pace and scale is still uncertain. How the market will form and which companies will win also remain unclear.

What we do know is that many cannabis investors have made fortunes with their stock picks. You could have doubled or tripled the value of your investment several times over by purchasing stocks like Green Organic Dutchman Holdings and Canopy Growth.

Recently, however, cannabis investors are losing their fortunes. Over the past six months, the stocks listed above have lost between 20% and 40% of their value. The period of over-exuberance is over. If you’re thinking about jumping in, now is your chance.

Hype cycles are real

Most investors are familiar with the term “hype cycle.” This methodology was created by Gartner to chart how a technology will evolve over time. The cycle itself is standardized, but where you place a technology on the chart is what matters. Gartner currently lists quantum computing, 5G technologies, and deep neural nets near the top of the hype cycle. The trick is to not buy at the top of the cycle where valuations are highest. Instead, you want to buy after peak expectations have been met.

For example, Gartner places “smart fabrics” and “augmented reality” in the expectations trough—that is, these technologies have already hit peak expectations, and now the public is undervaluing their potential. Compare how many times you’ve heard about quantum computing or 5G technologies with the popularity of smart fabrics. I’m sure you’d agree that the former have more hype than the latter. But that’s the point — people underestimate the impact of a technology in the moments before they go mainstream.

While cannabis isn’t a traditional technology, it’s following the standard hype cycle curve. For years, even decades, serious investors and market analysts ignored the industry’s potential. Only when widespread legalization efforts began bearing fruit did the industry garner respect.

Today, nearly every major research institution has analysts covering cannabis stocks. When they deployed coverage, the stock prices of many cannabis producers skyrocketed. Companies that never generated even $1 in revenue were trading at $1 billion market caps.

As with any other hype curve evolution, cannabis stocks then took a dive. Shares of Canopy Growth and Green Organic Dutchman are down more than 40% over the last 12 months. Analysts have cooled quickly. Ryan Macdonell of GMP Securities called Canopy Growth’s latest quarterly results “lacklustre.” Green Organic Dutchman recently missed revenue expectations by nearly 50%! If you’re looking to buy low, the time is getting close.

Cannabis 2.0

According to Barron’s, Canada will “allow producers to add vapes, edibles, beverages, and the popular CBD to their sales of the dried flower” by the end of this year. Many analysts expect this to add billions of dollars to the industry in new sales. Importantly, many of these products are higher margin, helping to stave off eventual commoditization of raw cannabis.

Both Canopy Growth and Green Organic Dutchman have been preparing to take the Cannabis 2.0 opportunity by storm, even though the market is now undervaluing the potential of these value-adding products. It’ll be a longer road now that the initial hype cycle has passed, but patient investors can now capitalize on falling expectations.

One tiny small-cap stock to bet on ahead of Cannabis 2.0 on October 17th…

The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.

Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.

Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.

This could be our next +1,000% winner in the cannabis space.

Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.

Click here to learn more!

More reading

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

Source: The Fool
Cannabis 2.0 Is Ready to Supercharge These Stocks
The Fool

The Motley Fool
Contributor for
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts